 |
| No, none of the 20 agents in the list below is going to do the work for you, but they could help you "conserve" the results, keep you lean on a bulk and/or avoid the hazardous Yoyo effect when you go off a die. |
It's actually normal that the introduction is the last part of an article I write. What's special about today's
SuppVersity article is thus not that I write the introduction at the end, but that I did not really know what I would be writing here, when I set out to compile the
unsorted (but not chaotic) list of potential anti-obesity agents below. All of them act by pathway(s) you as a
SuppVersity reader will have read about before, most prominently
AMPK, and the
peroxisome proliferator receptors (PPARs), of which the blockade of the obesogenic PPAR-gamma pathway, which is the main working principle of
CLA turned out to be
the go-to explanation for the ability of these agents to block
both the differentiation of adipocytes and the storage of triglycerides in existing fat cells.
20 more or less proven anti-obesity agents for the weekend
As you are about to see, the list, which was never intended to be complete, got pretty and I guess I could add a couple of additional items, if I spent more time digging. In order not to steal your and waste more of my precious time on this sunny (finally!) Sunday, I did yet decide to call it a day, when I hit the 20-items mark. Now it's up to you to invest some of your sunny Sunday time, to read up on the details.
On a side note: The "holy" vitamin D does the exact opposite, if you incubate preadipocytes with 25(OH)D(3) this will lead to a significant increase in the active 1,25(OH)(2)D(3) and enhanced adipogenesis in primary mouse. Reason enough for a group of Thai researchers to conclcude that "vitamin D status may [actually] regulate human adipose tissue growth and remodeling." (Nimitphong . 2012)
Vitamin A - Retinoic acid upregulates the expression of the adipogenesis inhibitors Pref-1, Sox9, and Kruppel-like factor 2 (KLF2) to "suppress adipogenesis in vivo and that the activity significantly contributes to the ability of the hormone to counteract diet-induced obesity." (Berry. 2012) Previous studies have also shown that all-trans-retionic acid directly increases the activity of PPARbeta/delta and so that Berry & Noy conclude "RA may be a uniquely efficacious agent in the therapy and prevention of the metabolic syndrome." (Berry. 2009) Similar results have been reported and conclusions have been drawn by Brun et al. and Sagara et al. (Brun. 2012; Sagara. 2013). Finally, Hisada et al report that - just like testosterone (learn more) - retinoic acid ensures that mesenchymal stem cells (MSCs) become osteoblasts (bone precursor cells), not fat cells (Hisada. 2013).
- Bromocriptine - If you do know it at all, then probably for it's ability to decrease the "milk hormone" prolaction. If you take a look at the broad spectrum of physiological effects of prolactin, the effect it has on the mammalian mammary gland is really negligible. A recent study from the Department of Biotechnology at the Daegu University in The Republic of Korea does now suggest that the inhibition of adipogenesis (formation of new fat cells) and lipogenesis (storage of lipids in existing fat cells) via decreased expressions of the adipogenic activators Pparα, Pparγ, and Cebpα, as well as major lipogenic target genes,
including Me1, Acc1, 6Pgd, Fasn, and Prkaa1 is one of these "auxiliary functions" (Mukherjee. 2013)
|
| EC also boosts erectile performance and testosterone (learn more) |
Ecklonia cava (EC) - or rather the dioxinodehydroeckol (DHE) molecules that are contained in this type of brown seaweed "exert[s] its anti-adipogenic effect on adipocyte differentiation through the activation and modulation of the AMPK signaling pathway" (Kim. 2010a). As a SuppVersity reader, you will be aware that this effect has been confirmed in in-vivo studies, later on (learn more).
What's probably Interestingly DHE is not the only anti-adipogenic agent in brown sea algae, Fucoidan, a sulfated
polysaccharide from brown seaweeds has likewise been reported to affect
the development of adipocytes. In 2010, Kim et al. were able to show that it targets the MAPK kinase pathway by inhibiting the the expression of both early CCAAT-enhancer-binding proteins
alpha (C/EBPalpha) and peroxisome proliferator-activated receptors gamma
(PPARgamma), as well as the late activating protein 2 (aP2) adipogenic
transcription factors (Kim. 2010b).
- Curcumin - While you my get the impression there was nothing curcumin cannot do (learn more), I am not whether the anti-PPAR gamma effects of curcumin are a result of it's anti-inflammatory effects or not... be that as it may, Lee et al. have demonstrated in 2009 already that the stimulatory effect curcumin exerts on the AMPK expression of adipocytes results in a down-regulation of PPAR-gamma in 3T3-L1 adipocytes (Lee. 2009).
- Resveratrol - Similar popularity, similar "cures it all" status and similar effects on AMPK and downstream PPAR-gamma expression in 3T3-L1 adipocytes... actually I would not need another bulletin point for resveratrol which acts by the exact same pathway(s) s curcumin to inhibit fat cell differentiation (Chen. 2011)
 |
| Creatine RT by Athletic Edge Nutrition; contains a cousin of ASL and is supposed to be another "super creatine" - True or False? The 2011 SuppVersity article has the answer (read it!). |
Artemisia sacrorum Ledeb. (ASL) - Extracts from the small shrub have been used in Oriental Medicine for centuries, in 2011 Yuan et al. were able to show that ASL "down-regulate[s] the adipogenesis-related gene expression of the
sterol regulatory element-binding protein 1c (SREBP1c) and its target
genes, such as fatty acid synthase (FAS), stearoyl-CoA desaturase 1
(SCD1) and glycerol-3-phosphate acyltransferase (GPAT) in a
concentration-dependent manner" (Yuan. 2011) The effects are meediated by a reduced expression of the peroxisome proliferator-activated receptor γ (PPARγ)
and of the CCAAT/enhancer binding protein-α (C/EBPα), both of which are key
transcription factors in adipogenesis.
With the concomitant reduction in adipocyte fatty acid
binding protein (aP2) gene expression, ASL is another potential anti-obesity agent of which Yuan et al. propose that it works its anti-adipogenic magic via AMPK activation. In view of the fact that the same is true for the fat accumulation in human liver cells, it could serve a viable tool "in the prevention of serious diseases such as fatty liver and type-2 diabetic mellitus" (Yuan. 2010). Related increases in fatty acid oxidation have been observed in a rodent study by Hong later in 2009 with another variety of Aertemisia, namely Artemesia Capillaris (Hong. 2010). The human equivalent dosage in this trial wast 8mg/kg of the ethyl acetate fraction of the shrub.
- Phosphorylated glucosamine - While you will probably remember that large doses of regular glucosamine have been associated with insulin resistance (see previous installment of "True Or False"), it's phosphorylated variety glucosamine-6-phosphat (PGlc), Kong et al. synthesized using methanesulfonic acid, phosphorus pentoxide (P(2)O(5)), NH(2)NH(2) and DMF "significantly reduced lipid accumulation during
adipocyte differentiation and induced down-regulation of peroxisome
proliferator-activated receptor-gamma, sterol regulatory element binding
protein 1 and CCAAT/enhancer binding protein-alpha in a dose-dependent
manner." (Kong. 2010)
 |
| Phosphorylated glucosamine works (like most of the anti-obesity agents, including the well-known conjugated linoleic acid by reducing the expression of PPAR-gamma (left). It's dose-dependent effects are yet not restricted to the peroxisome proliferator receptor, but affect the pro-adipogenic genes C/EBP-alpha and SREBP1, as well (right; Kong. 2010) |
What's also worth mentioning is that the in-vitro study from the Marine Bioprocess Research Center at the Pukyong National University in South Korea also revealed that PGcl also hampered the maturation of pre-adipocytes by
down-regulating adipocyte-specific gene promoters such as adipocyte
fatty acid binding protein, fatty acid synthase, lipoprotein lipase and
leptin. In conjunction "[t]hese results suggest that the inhibitory
effect of PGlc on adipocyte differentiation might be mediated through
the down-regulation of adipogenic transcription factors, such as
peroxisome proliferator-activated receptor-gamma, sterol regulatory
element binding protein 1 and CCAAT/enhancer binding protein-alpha,
which are related to the downstream adipocyte-specific gene promoters" (Kong. 2010)
 |
| Add. reads: "Temporary +100kcal/Day Cold Thermogenesis Response W/ Exotic Ginger Extract" (more) "250-1000mg of Freeze-Dried Ginger Reduce Visceral Fat Even When Rodents Are Fed an Obesogenic High Fat Diet" (more).
|
6-gingerol (6G) - The active ingredient in ginger has just been shown to block the obesity effects of the anti-diabetes med rosiglitazone (Tzeng. 2013). It does so by blocking the PPAR-gamma mediated effects of the "store the superfluous energy as body fat"-drug and was thus able to suppress the oil droplet accumulation and reduce the sizes of the
droplets in the course rosiglitazone(RSG)-induced adipocyte differentiation in 3T3-L1 cells. Since it also blunted the increased levels of
mRNA and protein in adipocyte-specific fatty acid binding protein 4 and
fatty acid synthase induced by RGZ, it can be expected that 6G will not only inhibit the accrual of new, but also the (re-)filling of existing fat cells.
- Piperine and capsaicin - In view of the fact that piperine is a "quasi-cousins" of 6-gingerol, it is actually not really surprising that it shares similar effects on the expression of PPAR-gamma (Park. 2012). It is therefore not surprising that the third member of this spicy triumvirate, i.e. capsaicin, shares the exact same PPAR-gamma reducing effects (Joo. 2010).
- Berberin - Contrary to many other items on the list, berberin's anti-PPAR-gamma effects are actually pretty well-known. There is ample evidence from in-vitro (Huang. 2006; Liu. 2009) and in-vivo (Lee. 2006) evidence that it blunts fat gain by increasing the catabolism of high energy intermediates, upregulating AMPK, modulating the expression of the GATA-2 and 3 gene and reducing the expression of (you guessed it) PPAR-gamma (Hu. 2009).
 |
| Table 1: Berberine content of various commercially available supplements (Brown 2008) |
Berberine has also been shown to improve endothelial function in man (Wang. 2009) and promote the "longevity and mitochondrial health gene" SIRT1 in obesity ridden, insulin resistant skeletal muscle (Gomes. 2012).
- Ginsenosides (spec. ginsenoside Rg3) - Just like ginereol (see above) ginsenoside Rg3 has been shown to block the adipogenic effects of the anditiabetic drug rosiglitazone via an AMPK/PPAR-gamma dependent pathway (Hwang. 2009). It may be worth mentioning that at least the effect triglyceride storage was not dose-dependent. Once a threshold amount of 40µM was reached, the adipocytes that were incubated with Rg3 did not "lose" any additional triglycerides, when the dosage was increased to 80µM.
On a side note:
Although promoted in the same health and longevity circles as CAPE, the
hailed "telomerase lengthener" Astraglaus is a PPAR-gamma promoter and
will thus "enhance the accumulation of lipid drops, and increase the
terminal differentiation of preadipocytes" (Liu. 2007)
Caffeic acid phenethyl ester (CAPE) - You've heard about the anti-inflammatory, muscle protective ability of this compound from bee propolis only recently (go back).
In addition to being a potent anti-inflammatory, the natural phenolic
compound that's also found in a variety of plants, has also been found
to block the conversion of mouse fibroblasts into fat cells (Juman.
2010). As for most of the other agents the effects of CAPE appear to be
mediated by a reduction inperoxisome proliferator-activated receptor
(PPAR) gamma and
CCAAT/enhancer-binding protein (C/EBPalpha) and concomittant reduction
isn fatty acid synthetase and the expression of adipocyte-specific fatty
acid binding protein (aP2).
- Lysimachia foenum-graecum (LFE) - LFE is a Chinese herb and well-known anti-inflammatory from Oriental Medicine. The anti-obesity effect of L. foenum-graecum
extract was first discovered by Seo et al., when they simply screened a whole host of potential natural agents for their anti-adipogenic effects. In 2011 the researchers found that "LFE blocked the differentiation of 3T3-L1
preadipocyte in a dose-dependent manner with an IC50 of 2.5 μg/ml". The underlying mechanism which has also been observed in an in-vivo rodent study with 100 mg/kg/day, are - how else could it be - mediated by the inhibition of PPARγ and C/EBPα
expression.
 |
| Effects of the administration of an lysimachia foenum-graecum ethanol extract on lipid and glucose metabolism and adipokine signalling in mice on an obesogenic diet (Seo. 2011) |
Moreover, LFE stimulated fatty acid oxidation
in an AMPK-dependent manner, greatly improved serum levels of obesity-related biomarkers
such as glucose, triglycerides, and adipocytokines leptin, adiponectin,
and resistin and lead to an effective decrease in total body weight gain in mice who received 30, 100, and 300 mg/kg/day
of an Lysimachia foenum-graecum ethanol extract (50:6; LFE) in addition to their obesogenic high fat diet (see figure above). The mice in the HFD + LFE group did simply have lower body weights, they also had a reduced amount of adipose tissues especially within the metabolically active and highly unhealthy abdominal
subcutaneous, epididymal, and perirenal adipose tissue.
 |
| Photos of the lean (A and D), HFD-fed (B and E) and HFD-fed + SRLE supplemented (C and F) mice in the Thounaojam study (2011). |
Sida rhomboidea. Roxb leaf extract (SRLE) - SRLE does only sound like the stuff many supplement companies used after the ban of mua huang (natural source of ephedrine). It is however a different variety of Sida (Batyάlaka, Sida cordifolia)... well, at least it is from the same family which lacks the CNS stimulating activity of mua huang. With its ability to prevent high fat diet (HFD) induced visceral
adiposity by down-regulation of PPARγ2 and leptin gene expression it could in fact work synergistically with ephedrine, though. After all the HED of the 24% w/w water extract Thounaojam et al. used to prevent the obesogenic effects of a hypercaloric high fat diet in their rodent study amounts to no more than ~40mg/kg and since SRLE has been shown to be non-toxic up to 3g/kg (in mice; HED ~240mg/kg) it would be interesting to see studies that probe whether it works in humans (Thounaojam. 2011).
- SH21B is an anti-obesity composition composed of seven herbs:
Scutellaria
baicalensis Georgi, Prunus armeniaca Maxim, Ephedra sinica Stapf,
Acorus gramineus Soland, Typha orientalis Presl, Polygala tenuifolia
Willd and Nelumbo nucifera Gaertner (active ingredients; see figure below) that has been used for the treatment
of obesity in traditional medical clinics in Korea and has recently been
shown to decrease the expression of major transcription factors of the
adipogenesis pathway and result in the down-regulation of lipid
metabolizing enzymes involved in the transport, uptake and synthesis of
lipids - unfortunatedly, only in vitro (Lee. 2009)
 |
| Effects of SH21B on fat droplet formation in 3T3-L1 cells (top) and size of adipocytes in adipose tissue. (bottom), as well as active ingredients in SH21B (based on Lee. 2009) |
As you can see in the stains from the adipose tissue of the above, the effects are clearly mediated by both an inhibition of the maturation of preadipocytes (top) and the inhibition of fat storage... now you tell me the world needs "new" anti-obesity agents!? I mean, it's quite obvious that the Koreans knew all along what keeps you lean ;-)
- Lactobacillus plantarum KY1032 cell extract - Before you begin to jubilee about the triumph march of probiotics, let me tell you this: I am not sure how on earth the remnants of a gut bacterium are supposed to reach your adipocyte tissue in a healthy individual without a leaky gut. Against that background I am not sure, whether it is even necessary to mention that Park et al. observed in 2011 that a cell exctract of the KY1032 strain of lactobacilli is another compound that can down-regulate the expression of peroxisome proliferator-activated receptor-γ2, CCAAT/enhancer binding
protein-α, fatty acid synthase, and adipocyte-fatty acid binding protein and thus blunt fat gains in vitro... ah, now I wrote it down, so I'll just leave it here ;-)
- Irvingia gabonensis seed extract - Likewise not a newcomer to the supplement the African / Southeast Asian tree, respectively an extract from its seeds has been shown to dose-dependently decrease the expression of PPAR-gamma in murine adipose cells in the petri dish in a 2008 study by scientists from Faculty of Science, University of Yaoundé in Cameroon and the Wake Forest University School of Medicine in Winston-Salem, USA (Oben. 2008).
 |
| The in-vitro study shows, CAF may inhibit fat storage, but it does not "squeeze" the fat out of the cells (data based on Kim. 2012) |
- Citrus aurantium falvenoids (CAF)- Despite the fact that most of you will probably have realized in N=1 experiments that citrus aurantium is a supplemental non-starter as a fatburner. It has (in-vitro) the ability to reduce the epxression of C/EBPβ and subsequently inhibit the activation of PPARγ and C/EBPα. So unless you have taken tons of pure CAF supplements during your last bulk, it is no wonder that you did not realize any effect from the fat burner you bought last summer. After all you are not storing any fat when you are dieting anyway... and I guess you have been dieting, when you took that product, right?
Apropos dieting, the data in the figure on the right also shows that citrus aurantium, alone, won't help with that. After all it lacks the ability to increase LPL and thus the release of free fatty acids from the triglyceride stores in your fat stores.
- Silibinin (from milk thistle) - You will probably have heard that milk thistle can help replenish the antioxidative defenses of your liver and thus prevent all sorts of systemic toxicities (learn more). At least in-vitro silibinin (aka silybin), the major active ingredient in silymarin, can also prevent the accumulation of triglycerides in existing, as well as the formation / maturation of future adipocytes. From a mechanistic point of view, the effect is mediated by the usual suspects respectively their downregulation (CAAT/enhancer binding protein-alpha, fatty acid synthase, sterol
response element binding protein 1c, adipocyte-specific lipid binding
protein, peroxisome proliferator-activated receptor gamma and
lipoprotein lipase; cf. Ka. 2009).
- Stem bromelain (SBM) - Just as so many of the previously mentioned agents, SBM, a specific member of the bromelain family you may know as "pineapple enzyme", is by no means a "new kid on the anti-fatloss block". Rather than that it has been used for centuries in traditional medicine as - guess what? - an anti-obesity agent. Now, I would never suggest that all TCM medicines work, but for stem bromelain it does at least seem as if the in-vitro studies, Dave et al. conducted about a year ago would support the notion that the ingestion of respective supplements can in fact exert beneficial effects on the accumulation of body fat (Dave. 2012).
 |
| Illustration of the mechanism and selected downstream effects of stem bromelain (SBM) on fat cells in the petri dish (compiled based on data from Dave. 2012) |
At the molecular level, SBM targets the same adipogenesic genes as (almost all) of the previous agents. What's interesting though, is the fact that the scsientists also found that "SBM's ability to repress
PPARγ expression seems to stem from its ability to inhibit Akt and
augment the TNFα pathway." (Dave. 2012) In other words, it's the increase in "bad" TNF-alpha and the decrease in the purportedly muscle, but in fact simply "mass building" Akt-TSC2-mTORC1 pathway that entails the apoptosis (controlled cell death) of mature adipocytes and lipolysis.
With the stem bromelain this comprehensive, but by no means all-encompassing list of "proven" (mostly only in vitro) anti-adipogenic agents, has come full circle. After all, Dave et al. point out that their data would indicate that stem bromelain, together with all-trans retinoic-acid (atRA), which is a metabolite of
vitamin A, the first item on our list "may be a potent
modulator of obesity by repressing the PPARγ-regulated adipogenesis
pathway at all stages and by augmenting TNFα-induced lipolysis and
apoptosis in mature adipocytes." (Dave. 2010).
It's not just beyond the scope of this article, but - in the majority of the cases simply not known - whether or not the TNFα increase is an integral part of the anti-obesity effects of
all of the aforementioned compounds. As far as the inhibition of PPAR-gamma is concerned things are different, though. With
PPAR-gamma being
the central "fat storage" switch, its deactivation and the entailing blockade of adipocyte differentiation,
pre-adipocyte maturation and triglyceride storage is currently probably the most effective anti-obesity mechanism we know. A mechanism that is way more fundamental than the diet-induced and stimulant / alpha/beta-agaonist (
caffeine,
ephedra,
clenbuterol,
yohimine) supported emptying of existing adipocyte triglyceride stores.
 |
| I know it's not popular, but in the case of vitamin D we already have evidence of it's obesity promoting effects (read more). It's straight forward experimental evidence, much contrary to the epidemiological guesswork on the basis of which people are popping vitamin D pills, these days. |
Keep in mind: Most of the data is derived from in-vitro studies. Few compounds do have actual evidence from rodent studies and the number of substances that showed beneficial effects in human studies is even smaller.
Nevertheless, the above list harbors a number of compounds which could be of great interest for the lean physical culturist, for whom (at least physique-wise) stuff like
vitamin D (note: the effects could be dose-dependent with benefits at low, and detrimental effects at high levels)
, astragalus and the rest of the healthy, but pro-adipogenic agents that can help obese individuals to stash away the tons of sugar and fat floating through their arteries are of little use.
Against that background I want to close this post with a warning, or I should say a reminder of the the fact that the effects of PPAR-gamma are physiologically important (e.g. prevention of lipotoxicity, Medina-Gomez. 2007) and go beyond "just making you fat" in how it would be worth striving to suppress it
altogether is thus questionable (suggested read:
CLA Destroys Body Fat). Since for all of the previously discussed agents that have in-vivo data to support their efficacy have
postivite, not negative "side effects" (think of curcumin, gingerol, ginseng, etc.), it is yet unlikely that the use of reasonable amounts of one or a stack of many of them is going to harm you.
Just keep in mind: The goal should be to keep the PPAR-gamma activity in check, not to annihilate it. Consequently you should not and cannot expect to be able to "eat whatever you want and still stay lean" by supplementing with any of the agents above. On the other hand, they can hardly be even less useful than the vast majority of currently available arsenal of OTC "fat burners" ;-)
References:
- Berry DC, Noy N. All-trans-retinoic acid represses obesity and insulin
resistance by activating both peroxisome proliferation-activated receptor
beta/delta and retinoic acid receptor. Mol Cell Biol. 2009 Jun;29(12):3286-96.
- Berry DC, DeSantis D, Soltanian H, Croniger CM, Noy N. Retinoic acid
upregulates preadipocyte genes to block adipogenesis and suppress diet-induced
obesity. Diabetes. 2012 May;61(5):1112-21.
- Brown PN, Roman MC. Determination of hydrastine and berberine in goldenseal
raw materials, extracts, and dietary supplements by high-performance liquid
chromatography with UV: collaborative study. J AOAC Int. 2008
Jul-Aug;91(4):694-701.
- Brun PJ, Yang KJ, Lee SA, Yuen JJ, Blaner WS. Retinoids: Potent regulators of
metabolism. Biofactors. 2012 Dec 22. doi: 10.1002/biof.1056.
- Chen S, Li Z, Li W, Shan Z, Zhu W. Resveratrol inhibits cell differentiation
in 3T3-L1 adipocytes via activation of AMPK. Can J Physiol Pharmacol. 2011
Nov;89(11):793-9.
- Gomes AP, Duarte FV, Nunes P, Hubbard BP, Teodoro JS, Varela AT, Jones JG,
Sinclair DA, Palmeira CM, Rolo AP. Berberine protects against high fat
diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent
mitochondrial biogenesis. Biochim Biophys Acta. 2012 Feb;1822(2):185-95.
- Hisada K, Hata K, Ichida F, Matsubara T, Orimo H, Nakano T, Yatani H,
Nishimura R, Yoneda T. Retinoic acid regulates commitment of undifferentiated
mesenchymal stem cells into osteoblasts and adipocytes. J Bone Miner Metab. 2013
Jan;31(1):53-63.
- Hong JH, Hwang EY, Kim HJ, Jeong YJ, Lee IS. Artemisia capillaris inhibits
lipid accumulation in 3T3-L1 adipocytes and obesity in C57BL/6J mice fed a high
fat diet. J Med Food. 2009 Aug;12(4):736-45.
- Hu Y, Davies GE. Berberine increases expression of GATA-2 and GATA-3 during
inhibition of adipocyte differentiation. Phytomedicine. 2009 Sep;16(9):864-73.
doi: 10.1016/j.phymed.2009.03.002. Epub 2009 Apr 28.
- Huang C, Zhang Y, Gong Z, Sheng X, Li Z, Zhang W, Qin Y. Berberine
inhibits 3T3-L1 adipocyte differentiation through the PPARgamma
pathway. Biochem Biophys Res Commun. 2006;348:571–578.
- Hwang JT, Lee MS, Kim HJ, Sung MJ, Kim HY, Kim MS, Kwon DY. Antiobesity effect
of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother
Res. 2009 Feb;23(2):262-6.
- Joo JI, Kim DH, Choi JW, Yun JW. Proteomic analysis for antiobesity potential
of capsaicin on white adipose tissue in rats fed with a high fat diet. J Proteome
Res. 2010 Jun 4;9(6):2977-87.
- Juman S, Yasui N, Okuda H, Ueda A, Negishi H, Miki T, Ikeda K. Caffeic acid
phenethyl ester inhibits differentiation to adipocytes in 3T3-L1 mouse
fibroblasts. Biol Pharm Bull. 2010;33(9):1484-8.
- Ka SO, Kim KA, Kwon KB, Park JW, Park BH. Silibinin attenuates adipogenesis in
3T3-L1 preadipocytes through a potential upregulation of the insig pathway. Int J
Mol Med. 2009 May;23(5):633-7.
- Kim SK, Kong CS. Anti-adipogenic effect of dioxinodehydroeckol via AMPK
activation in 3T3-L1 adipocytes. Chem Biol Interact. 2010a Jun 7;186(1):24-9.
- Kim KJ, Lee OH, Lee BY. Fucoidan, a sulfated polysaccharide, inhibits
adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1
preadipocytes. Life Sci. 2010b May 22;86(21-22):791-7.
- Kim GS, Park HJ, Woo JH, Kim MK, Koh PO, Min W, Ko YG, Kim CH, Won CK, Cho JH.
Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling
pathway in 3T3-L1 cells. BMC Complement Altern Med. 2012 Apr 3;12:31.
- Kong CS, Kim JA, Eom TK, Kim SK. Phosphorylated glucosamine inhibits
adipogenesis in 3T3-L1 adipocytes. J Nutr Biochem. 2010 May;21(5):438-43.
- Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh
WK, Kim CT, et al. Berberine, a natural plant product, activates
AMP-activated protein kinase with beneficial metabolic effects in
diabetic and insulin-resistant states. Diabetes. 2006;55:2256–2264.
- Lee YK, Lee WS, Hwang JT, Kwon DY, Surh YJ, Park OJ. Curcumin exerts
antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and
antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J Agric Food
Chem. 2009 Jan 14;57(1):305-10.
- Lee H, Kang R, Yoon Y. SH21B, an anti-obesity herbal composition, inhibits fat
accumulation in 3T3-L1 adipocytes and high fat diet-induced obese mice through
the modulation of the adipogenesis pathway. J Ethnopharmacol. 2010 Feb
17;127(3):709-17.
- Liu Y, Wang WJ, Chen WH, Yin J. [Effects of Astragalus polysaccharides on
proliferation and differentiation of 3T3-L1 preadipocytes]. Zhong Xi Yi Jie He
Xue Bao. 2007 Jul;5(4):421-6.
- Liu Y, Lou SY, He YM. [Effects of berberine on cell proliferation, peroxisome
proliferation activated receptor gamma, CAAT/enhancer binding protein mRNA and
protein expression in 3T3-L1 pre-adipocytes]. Zhongguo Zhong Xi Yi Jie He Za Zhi.
2008 Nov;28(11):1005-9.
- Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis
RK, Jimenez-Linan M, Blount M, Yeo GS, Lopez M, Seppänen-Laakso T, Ashcroft FM,
Oresic M, Vidal-Puig A. PPAR gamma 2 prevents lipotoxicity by controlling adipose
tissue expandability and peripheral lipid metabolism. PLoS Genet. 2007 Apr
27;3(4):e64.
- Mukherjee R, Yun JW. Bromocriptine inhibits adipogenesis and lipogenesis by
agonistic action on α2-adrenergic receptor in 3T3-L1 adipocyte cells. Mol Biol
Rep. 2013 May;40(5):3783-92.
- Nimitphong H, Holick MF, Fried SK, Lee MJ. 25-hydroxyvitamin D₃ and
1,25-dihydroxyvitamin D₃ promote the differentiation of human subcutaneous
preadipocytes. PLoS One. 2012;7(12):e52171.
- Oben JE, Ngondi JL, Blum K. Inhibition of Irvingia gabonensis seed extract
(OB131) on adipogenesis as mediated via down regulation of the PPARgamma and
leptin genes and up-regulation of the adiponectin gene. Lipids Health Dis. 2008
Nov 13;7:44.
- Park DY, Ahn YT, Huh CS, Jeon SM, Choi MS. The inhibitory effect of
Lactobacillus plantarum KY1032 cell extract on the adipogenesis of 3T3-L1 Cells.
J Med Food. 2011 Jun;14(6):670-5.
- Park UH, Jeong HS, Jo EY, Park T, Yoon SK, Kim EJ, Jeong JC, Um SJ. Piperine,
a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity
in 3T3-L1 cells. J Agric Food Chem. 2012 Apr 18;60(15):3853-60.
- Sagara C, Takahashi K, Kagechika H, Takahashi N. Molecular mechanism of
9-cis-retinoic acid inhibition of adipogenesis in 3T3-L1 cells. Biochem Biophys
Res Commun. 2013 Mar 29;433(1):102-7.
- Seo JB, Choe SS, Jeong HW, Park SW, Shin HJ, Choi SM, Park JY, Choi EW, Kim
JB, Seen DS, Jeong JY, Lee TG. Anti-obesity effects of Lysimachia foenum-graecum
characterized by decreased adipogenesis and regulated lipid metabolism. Exp Mol
Med. 2011 Apr 30;43(4):205-15.
- Thounaojam MC, Jadeja RN, Ramani UV, Devkar RV, Ramachandran AV. Sida
rhomboidea. Roxb Leaf Extract Down-Regulates Expression of PPARγ2 and Leptin
Genes in High Fat Diet Fed C57BL/6J Mice and Retards in Vitro 3T3L1 Pre-Adipocyte
Differentiation. Int J Mol Sci. 2011;12(7):4661-77.
- Tzeng TF, Chang CJ, Liu IM. 6-Gingerol Inhibits Rosiglitazone-Induced
Adipogenesis in 3T3-L1 Adipocytes. Phytother Res. 2013 Mar 21.
- Wang JM, Yang Z, Xu MG, Chen L, Wang Y, Su C, Tao J.
Berberine-induced decline in circulating CD31+/CD42- microparticles is
associated with improvement of endothelial function in humans. Eur J Pharmacol. 2009;614:77–83.
- Yuan HD, Yuan HY, Chung SH, Jin GZ, Piao GC. An active part of Artemisia
sacrorum Ledeb. attenuates hepatic lipid accumulation through activating
AMP-activated protein kinase in human HepG2 cells. Biosci Biotechnol Biochem.
2010;74(2):322-8.
- Yuan HD, Piao GC. An active part of Artemisia sacrorum Ledeb. inhibits
adipogenesis via the AMPK signaling pathway in 3T3-L1 adipocytes. Int J Mol Med.
2011 Apr;27(4):531-6.
